STOX1 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of STOX1, a transcription factor belonging to the forkhead box (FOX) family of proteins. STOX1 plays a crucial role in regulating gene expression related to cellular development, differentiation, and various stress response pathways. Like other transcription factors, STOX1 binds to specific DNA sequences in the promoter regions of its target genes, modulating their transcription either by activating or repressing them. It is involved in controlling several biological processes, including cellular growth, oxidative stress responses, and potentially placental development. Inhibitors of STOX1 work by disrupting its ability to bind to DNA or interact with other transcriptional machinery, thereby modulating the expression of genes under its regulatory control.
The mechanism of action for STOX1 inhibitors can vary. Some inhibitors may bind directly to the DNA-binding domain of STOX1, preventing it from attaching to the target promoter regions of its regulated genes. Others may interact with domains that mediate the formation of transcriptional complexes, thus preventing STOX1 from recruiting other essential transcriptional factors or co-regulators necessary for gene expression. Inhibition of STOX1 can lead to downstream effects on a range of cellular processes, as the transcriptional networks under STOX1's control are disrupted. This can alter cell growth, differentiation, and the response to environmental stresses. Research into STOX1 inhibitors provides valuable insights into the molecular pathways governed by this transcription factor, shedding light on its role in developmental processes and gene regulatory networks. Understanding how STOX1 inhibition affects gene expression enhances our comprehension of the broader regulatory mechanisms that orchestrate cellular functions and responses to external stimuli.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Involved in gene transcription and cell differentiation. Retinoic Acid could influence STOX1 function indirectly through pathways affecting cellular differentiation and development. | ||||||
Folic Acid | 59-30-3 | sc-204758 | 10 g | $72.00 | 2 | |
Essential for DNA synthesis and repair. Folic Acid supplementation could indirectly affect STOX1 activity by modulating DNA synthesis and methylation, potentially influencing gene regulation and placental development. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
A form of estrogen, involved in reproductive and developmental processes. Estradiol could indirectly impact STOX1 function by influencing hormonal pathways and cellular proliferation. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $51.00 $292.00 | 3 | |
A hormone important in pregnancy and embryogenesis. Progesterone could indirectly influence STOX1 activity through its role in placental development and maintenance. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
A selective estrogen receptor modulator, used in breast cancer research. Tamoxifen could indirectly affect STOX1 by modulating estrogen receptor signaling pathways, potentially impacting cell proliferation and differentiation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
A natural compound with various biological activities, including anti-inflammatory and anticancer properties. Curcumin could indirectly influence STOX1's role in cell proliferation and differentiation. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
Important for various biological processes including cell growth and development. Vitamin D might indirectly affect STOX1 function by modulating cellular differentiation and immune responses. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $56.00 | 1 | |
An immunomodulatory drug, could indirectly influence STOX1 by modulating immune responses and cellular processes relevant in placental development and preeclampsia. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, a key regulator of cell growth and metabolism. Rapamycin could indirectly impact STOX1 activity through its influence on cell proliferation and growth pathways. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
An antidiabetic drug that impacts cellular metabolism. Metformin could indirectly affect STOX1 by influencing metabolic pathways and cellular proliferation. | ||||||